Record-high Q2 sales and profits were driven by robust EMR system demand and cost controls. Full-year guidance is maintained, with strong progress toward targets and continued growth in both Healthcare and Marketing Solutions segments.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.